↓ Skip to main content

Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo

Overview of attention for article published in BMC Cancer, April 2011
Altmetric Badge

Mentioned by

twitter
2 tweeters

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo
Published in
BMC Cancer, April 2011
DOI 10.1186/1471-2407-11-136
Pubmed ID
Authors

Susan E Spiller, Naomi J Logsdon, Lindsey A Deckard, Harald Sontheimer

Abstract

Medulloblastoma is a highly malignant pediatric brain tumor that requires surgery, whole brain and spine irradiation, and intense chemotherapy for treatment. A more sophisticated understanding of the pathophysiology of medulloblastoma is needed to successfully reduce the intensity of treatment and improve outcomes. Nuclear factor kappa-B (NFκB) is a signaling pathway that controls transcriptional activation of genes important for tight regulation of many cellular processes and is aberrantly expressed in many types of cancer.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
Spain 1 2%
Germany 1 2%
Austria 1 2%
Unknown 51 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 30%
Student > Ph. D. Student 9 16%
Other 7 13%
Student > Bachelor 6 11%
Student > Master 4 7%
Other 12 21%
Unknown 1 2%
Readers by discipline Count As %
Agricultural and Biological Sciences 22 39%
Medicine and Dentistry 15 27%
Biochemistry, Genetics and Molecular Biology 5 9%
Neuroscience 5 9%
Immunology and Microbiology 2 4%
Other 4 7%
Unknown 3 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2013.
All research outputs
#11,231,298
of 17,351,915 outputs
Outputs from BMC Cancer
#3,036
of 6,308 outputs
Outputs of similar age
#78,939
of 131,948 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 17,351,915 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,308 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 131,948 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them